|
COVID-19 has demonstrated in a quite dramatic way the huge impact of a global threat on public health and economy. While the COVID-19 crisis took us by surprise, our world faces a silent threat that is predictable and preventable, writes Hubertus Von Baumbach, CEO of Boehringer Ingelheim.
The rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR – is a looming global crisis we have known for quite some time.
Antibiotic resistance kills about 700,000 people globally every year. Superbugs that are resistant to antibiotics are on the rise, affecting every aspect of medicine today. We rely on the availability of effective antibiotics to be able to do everything from wisdom tooth extractions to cancer chemotherapy.
|
